AbCellera Biologics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 02/14/2025 | 27.53 M | $80.65 M | 0.00% | 9.34% |
BAILLIE GIFFORD & CO | 01/31/2025 | 12.24 M | $35.85 M | -5.10% | 4.15% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 10.62 M | $31.13 M | 0.00% | 3.60% |
CAPITAL WORLD INVESTORS | 02/13/2025 | 7.93 M | $23.25 M | 100.00% | 2.69% |
PROSIGHT MANAGEMENT, LP | 02/14/2025 | 7.35 M | $21.54 M | -19.05% | 2.49% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 4.50 M | $13.19 M | -1.96% | 1.53% |
ORBIMED ADVISORS LLC | 02/14/2025 | 4.18 M | $12.25 M | 0.00% | 1.42% |
ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 4.11 M | $12.03 M | 0.00% | 1.39% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.10 M | $12.00 M | 2.71% | 1.39% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 3.26 M | $9.54 M | 28.56% | 1.10% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 2.61 M | $7.64 M | 19.78% | 0.88% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.58 M | $7.57 M | 12.30% | 0.88% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 2.49 M | $7.29 M | -15.60% | 0.84% |
UBS GROUP AG | 02/14/2025 | 1.98 M | $5.79 M | 8,984.15% | 0.67% |
GUARDIAN PARTNERS INC. | 02/11/2025 | 1.79 M | $5.41 M | 100.00% | 0.61% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.48 M | $4.34 M | 96.68% | 0.50% |
NORGES BANK | 02/12/2025 | 1.28 M | $3.76 M | 100.00% | 0.44% |
NOVO HOLDINGS A/S | 02/14/2025 | 1.13 M | $3.30 M | 0.00% | 0.38% |
OPALEYE MANAGEMENT INC. | 02/14/2025 | 965,000 | $2.83 M | 20.63% | 0.33% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 928,594 | $2.72 M | -15.32% | 0.31% |
FEDERATED HERMES, INC. | 02/13/2025 | 916,237 | $2.68 M | -59.86% | 0.31% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 589,213 | $1.73 M | 143.61% | 0.20% |
INTELLECTUS PARTNERS, LLC | 02/07/2025 | 547,533 | $1.60 M | 0.37% | 0.19% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 417,396 | $1.22 M | 78.33% | 0.14% |
ROYAL BANK OF CANADA | 02/14/2025 | 406,991 | $1.19 M | -0.10% | 0.14% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/10/2025 | 340,267 | $959,553 | 0.00% | 0.12% |
STATE STREET CORP | 02/14/2025 | 324,802 | $951,670 | 0.49% | 0.11% |
DNB ASSET MANAGEMENT AS | 02/12/2025 | 305,579 | $895,346 | 424.72% | 0.10% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 299,813 | $878,452 | 45.75% | 0.10% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 281,795 | $826,000 | 100.00% | 0.10% |
JPMORGAN CHASE & CO | 02/12/2025 | 281,033 | $823,426 | -21.00% | 0.10% |
HRT FINANCIAL LP | 02/14/2025 | 250,226 | $733,000 | 92.62% | 0.08% |
PIER 88 INVESTMENT PARTNERS LLC | 02/12/2025 | 236,900 | $694,117 | 21.18% | 0.08% |
PEAK6 LLC | 02/13/2025 | 199,995 | $585,985 | 100.00% | 0.07% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 178,839 | $521,000 | 1,237.51% | 0.06% |
ENTRYPOINT CAPITAL, LLC | 02/11/2025 | 168,682 | $494,238 | 43.98% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 166,300 | $487,259 | 74.14% | 0.06% |
JANE STREET GROUP, LLC | 02/14/2025 | 128,407 | $376,232 | 21.19% | 0.04% |
TRUEMARK INVESTMENTS, LLC | 02/12/2025 | 124,089 | $363,581 | -7.68% | 0.04% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 117,830 | $345,242 | 0.00% | 0.04% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 116,887 | $342,479 | -0.20% | 0.04% |
ARCHPOINT INVESTORS | 02/13/2025 | 115,055 | $337,111 | 0.00% | 0.04% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 113,773 | $333,354 | 0.11% | 0.04% |
TD WATERHOUSE CANADA INC. | 02/13/2025 | 104,594 | $306,460 | -55.00% | 0.04% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 104,365 | $271,600 | 0.11% | 0.04% |
GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 103,610 | $303,577 | 100.00% | 0.04% |
XTX TOPCO LTD | 02/13/2025 | 91,754 | $268,839 | 100.00% | 0.03% |
MOLONEY SECURITIES ASSET MANAGEMENT, LLC | 01/28/2025 | 90,400 | $264,872 | 100.00% | 0.03% |
01/31/2025 | 89,616 | $289,460 | -5.78% | 0.03% | |
GROUP ONE TRADING, L.P. | 02/14/2025 | 89,204 | $261,368 | 18.96% | 0.03% |
AbCellera Biologics Inc. institutional Ownership - FAQ's
During the previous two years, 178 institutional investors and hedge funds held shares of AbCellera Biologics Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 27.53 M
BAILLIE GIFFORD & CO: 12.24 M
VOYA INVESTMENT MANAGEMENT LLC: 10.62 M
Capital World Investors: 7.93 M
Prosight Management, LP: 7.35 M
UBS ASSET MANAGEMENT AMERICAS INC: 4.5 M
38.62% of AbCellera Biologics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 133.64 M shares in the last 24 months. This purchase volume represents approximately $442.34 M in transactions.